Ok so neu has made it very clear that tox studies and commercialisation work needs to be done prior to p3 starting and I’d say u can pretty much guarantee that’s where r/d money is going
If they were going alone in p3, which I put at the same chance as lopez’s 6c CR (for a number of reasons) the ramp up costs in preparation for that would be much higher than 1.8 mill
Anyway u lot keep jumping at shadows it’s keeping me entertained while mgmt put a bow on this
Ok so neu has made it very clear that tox studies and...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.61 |
Change
0.280(2.10%) |
Mkt cap ! $1.739B | |||
| Open | High | Low | Value | Volume |
| $13.49 | $13.64 | $13.30 | $4.821M | 356.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3602 | $13.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.66 | 1655 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |